Cite
MLA Citation
Matthias D. Hofer. “Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal.” Fundamental & clinical pharmacology, vol. 32, 2018, p. 547. http://access.bl.uk/ark:/81055/vdc_100068804991.0x00003e
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Matthias D. Hofer. “Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal.” Fundamental & clinical pharmacology, vol. 32, 2018, p. 547. http://access.bl.uk/ark:/81055/vdc_100068804991.0x00003e